Literature DB >> 20970154

Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs.

Luis M Agosto1, Megan K Liszewski, Angela Mexas, Erin Graf, Matthew Pace, Jianqing J Yu, Avinash Bhandoola, Una O'Doherty.   

Abstract

HIV establishes a latent reservoir early in infection that is resistant to anti-retroviral therapy and has a slow rate of decay. It is thought that the majority of HIV DNA in treated patients is integrated since unintegrated HIV DNA appears to be unstable. Thus, to monitor the HIV latent reservoir, total HIV DNA is commonly measured in PBMC from infected individuals. We investigated how often total approaches integrated HIV DNA in treated patients. To do this, we first assessed how accurate our integration assay is and determined the error in our measurements of total and integrated HIV DNA. We demonstrated an excess of total over integrated HIV DNA was present in a subset of patients, suggesting that measurements of total HIV DNA do not always correlate to the level of integration. Determining the cause of this excess and its frequency may have important implications for understanding HIV latent reservoir maintenance.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20970154      PMCID: PMC3253773          DOI: 10.1016/j.virol.2010.08.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

1.  Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication.

Authors:  Bharat Ramratnam; Ruy Ribeiro; Tian He; Chris Chung; Viviana Simon; Jeroen Vanderhoeven; Arlene Hurley; Linqi Zhang; Alan S Perelson; David D Ho; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2004-01-01       Impact factor: 3.731

2.  Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.

Authors:  Xiaobin Lu; Laurent Humeau; Vladimir Slepushkin; Gwendolyn Binder; Qiao Yu; Tatiana Slepushkina; Ziping Chen; Randall Merling; Brian Davis; Yung-Nien Chang; Boro Dropulic
Journal:  J Gene Med       Date:  2004-09       Impact factor: 4.565

3.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  Infection of monocyte/macrophages by human T lymphotropic virus type III.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Loss of neoplastic properties in vitro. II. Observations on KB sublines.

Authors:  G E Foley; A H Handler; P M Lynch; S R Wolman; C S Stulberg; H Eagle
Journal:  Cancer Res       Date:  1965-09       Impact factor: 12.701

6.  Quantitative infectivity assay for HIV-1 and-2.

Authors:  P L Nara; P J Fischinger
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

Review 7.  Repetitive sequences in eukaryotic DNA and their expression.

Authors:  W R Jelinek; C W Schmid
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

8.  Integration is not necessary for expression of human immunodeficiency virus type 1 protein products.

Authors:  M Stevenson; S Haggerty; C A Lamonica; C M Meier; S K Welch; A J Wasiak
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  HIV-1 replication is controlled at the level of T cell activation and proviral integration.

Authors:  M Stevenson; T L Stanwick; M P Dempsey; C A Lamonica
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

10.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

Authors:  M I Bukrinsky; T L Stanwick; M P Dempsey; M Stevenson
Journal:  Science       Date:  1991-10-18       Impact factor: 63.714

View more
  20 in total

1.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR.

Authors:  Steven M Lada; Karissa Huang; D Jake VanBelzen; Luis J Montaner; Una O'Doherty; Douglas D Richman
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

3.  Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies.

Authors:  Claire Vandergeeten; Rémi Fromentin; Esther Merlini; Mariam B Lawani; Sandrina DaFonseca; Wendy Bakeman; Amanda McNulty; Moti Ramgopal; Nelson Michael; Jerome H Kim; Jintanat Ananworanich; Nicolas Chomont
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.

Authors:  Zachary Strongin; Radwa Sharaf; D Jake VanBelzen; Jeffrey M Jacobson; Elizabeth Connick; Paul Volberding; Daniel J Skiest; Rajesh T Gandhi; Daniel R Kuritzkes; Una O'Doherty; Jonathan Z Li
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

Review 5.  HIV-1 Eradication: Early Trials (and Tribulations).

Authors:  Adam M Spivak; Vicente Planelles
Journal:  Trends Mol Med       Date:  2015-12-12       Impact factor: 11.951

6.  Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.

Authors:  Angela M Mexas; Erin H Graf; Matthew J Pace; Jianqing J Yu; Emmanouil Papasavvas; Livio Azzoni; Michael P Busch; Michele Di Mascio; Andrea S Foulkes; Stephen A Migueles; Luis J Montaner; Una O'Doherty
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

Review 7.  Eliminating the HIV reservoir.

Authors:  Alain Lafeuillade
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

8.  Ex Vivo Differentiation of Resting CD4+ T Lymphocytes Enhances Detection of Replication Competent HIV-1 in Viral Outgrowth Assays.

Authors:  Elizabeth R Wonderlich; Monica D Reece; Deanna A Kulpa
Journal:  Methods Mol Biol       Date:  2022

Review 9.  How to best measure HIV reservoirs?

Authors:  Christine Rouzioux; Douglas Richman
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

10.  Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.

Authors:  Erin H Graf; Angela M Mexas; Jianqing J Yu; Farida Shaheen; Megan K Liszewski; Michele Di Mascio; Stephen A Migueles; Mark Connors; Una O'Doherty
Journal:  PLoS Pathog       Date:  2011-02-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.